EMA — authorised 12 May 2016
- Marketing authorisation holder: Swedish Orphan Biovitrum AB
- Status: approved
🇪🇺 Alprolix in European Union
EMA authorised Alprolix on 12 May 2016
Marketing authorisation
Alprolix in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Alprolix approved in European Union?
Yes. EMA authorised it on 12 May 2016.
Who is the marketing authorisation holder for Alprolix in European Union?
Swedish Orphan Biovitrum AB holds the EU marketing authorisation.